Adalimumab Effective in Patients With Total Spinal Ankylosis

Those of us who treats ankylosing spondylitis will realise how difficult it is to treat this inevitably progressive disease. This study suggests improvement in patients with spinal ankylosis given an anti TNF alpha, adalimumab.

One major obstacle in Malaysia remains the cost. Many would argue that ultimately the disease is not cured but only offers symptomatic relief. Would one spend your life savings for some relief of pain? i think not.